speb/financial-data huggingface dataset:
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -1976076000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -2064640000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 1618602000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1618602000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 7505080000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1719904000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 655466000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 168919000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 13605000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 13605000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -394353000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 143186000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 143186000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 9946300000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 9946300000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 297000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Sale Of Investment Properties: 954313000.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 11642000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 238286000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 611251000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Share Issued: 12829889.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 12829889.00
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: 0.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Special Income Charges: 691860000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 15248063000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 15248063000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 12404913000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 12404913000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 191369723.47
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Tax Provision: 862209000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 114937000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.25
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.29
NEULANDLAB.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -747262000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Total Assets: 21798816000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 21798816000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 16155337000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 16155337000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Total Debt: 1571376000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1571376000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 15248063000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 15248063000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Total Expenses: 11678044000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 2941780000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 6550753000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 6550753000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 10403847000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 10403847000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1893894000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1893894000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 25077000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 885000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 885000.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 768687000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
NEULANDLAB.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 768687000.00
NEULANDLAB.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Work In Process: 1553020000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 1553020000.00
NEULANDLAB.NS balance_sheet (annual, 2025-03-31) — Working Capital: 6738110000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 6738110000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1255346000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 2927527000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 12834718.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 10.83
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1529187000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 201895000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 201895000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 12834718.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 10.83
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 139000000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — EBIT: 221553000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — EBITDA: 423448000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 1398340000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 45849000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 45849000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Net Income: 139000000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 139000000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 139000000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 139000000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 139000000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 139000000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -45849000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -45849000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 423448000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 139000000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Operating Income: 142994000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 2927527000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 78559000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 318800000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 175704000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1529187000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 201895000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 36704000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 2784533000.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
NEULANDLAB.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1517040000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 5142731000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2898237000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 4409214000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 130018000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 12830030.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 75.49
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1043404000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 129005000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 413418000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1796574000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 129005000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 16201551000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 1399535000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2295652000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 12655663000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 32347000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 709629000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 741976000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 6442820000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 24477000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 225415000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 225415000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 12830030.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 75.49
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 968539000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — EBIT: 1348036000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — EBITDA: 1573451000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 2794610000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2883201000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 9275415000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 2847079000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 53671000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 53671000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 5478982000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 17803423000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 130018000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1011057000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 892243000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1903300000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 71692000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 1188454000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Net Income: 968539000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 968539000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 968539000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 968539000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 968539000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 968539000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -53671000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -53671000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 9275415000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 13318350000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 720976000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1573451000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 968539000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Operating Income: 1330039000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 5142731000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 12829889.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 970893000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1924714000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 16072546000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 88591000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 252755000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 17997000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 487902000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 7875880000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 1383156000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Payables: 2898744000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 1294365000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2295652000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 225415000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 12829889.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 16201551000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 13318350000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 325826000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 25340339000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 17093794000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2645276000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 16201551000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 3812692000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 9138788000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 12684676000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2695968000.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 507000.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
NEULANDLAB.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
NEULANDLAB.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 6212843000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1428763000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 4397093000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 12831088.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 31.62
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2436197000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 239196000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 239196000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 12831088.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 31.62
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 405719000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — EBIT: 612657000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — EBITDA: 851853000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1960896000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 67903000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 67903000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Net Income: 405719000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 405719000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 405719000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 405719000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 405719000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 405719000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -67903000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -67903000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 851853000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 405719000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Operating Income: 532133000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 4397093000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 80524000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 301244000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 544754000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2436197000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 239196000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 139035000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 3864960000.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
NEULANDLAB.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — +Operating Expense: 4949788000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1729956000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — +Total Revenue: 19321190000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 7762503000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 2691441000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2691441000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 5413531000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 5413531000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -3335597000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -3335597000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 4977735000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 4977735000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -2901000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -2901000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Amortization: 22428000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 22428000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 19822000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 19822000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 12829889.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 12830152.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Basic EPS: 283.71
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 165.76
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1319304000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 3752744000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 3752744000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -3971321000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 1046591000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1046591000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 129005000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 129005000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 766704000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 766704000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 3266704000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 3266704000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -153959000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 0.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 0.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 766704000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 766704000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -1245295000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -107210000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 1930250000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Change In Payable: 161491000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -2242118000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -1414224000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -560771000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Common Stock: 129005000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 129005000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -153959000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 18744729000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 18744729000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 2507101000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 2507101000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 9471166000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3210130000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Current Assets: 14831288000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 14831288000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 49643000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 49643000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Current Debt: 356658000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 356658000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 406301000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 406301000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 7101980000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 7101980000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 23078000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 23078000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Depreciation: 894967000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 917395000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 917395000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 250889000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 894967000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 250889000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 12829889.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 12830152.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Diluted EPS: 283.71
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 165.76
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 3639984000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2126726000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 2328000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 2328000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — EBIT: 5076738000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — EBIT: 2946999000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — EBITDA: 5994133000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — EBITDA: 3197888000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 8171000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — End Cash Position: 766704000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 209754000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 385782000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 385782000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Fixed Assets Revaluation Reserve: 8389000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Fixed Assets Revaluation Reserve: 8389000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -504517000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -75547000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 52738000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 521241000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Goodwill: 2794610000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 2794610000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 2857268000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2857268000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 5416432000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 5416432000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 14765574000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 14765574000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Gross Profit: 9850024000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 4552373000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Interest Expense: 186967000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 72051000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 186967000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 72051000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Interest Income: 100554000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 100554000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -239945000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 86074000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Inventory: 5102864000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 5102864000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 20710860000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 20710860000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -4237329000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 0.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 0.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 19822000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 19822000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 1056093000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 506781000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 506781000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 996948000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 996948000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 1609473000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1609473000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2606421000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2606421000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 1056093000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -447178000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 158611000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 158611000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 7998948000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 7998948000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Net Debt: 1199427000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 1199427000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 13495000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Net Income: 3639984000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Net Income: 2126726000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 3639984000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2126726000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 3639984000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2126726000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3639984000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2126726000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 3639984000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2126726000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 4889771000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 3639984000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2126726000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Net Interest Income: -138920000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -72051000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Net Investment Properties Purchase And Sale: 0.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -361345000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 608915000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 608915000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -138920000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -72051000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Net PPE: 11429977000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 11429977000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -3962058000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 15887461000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 15887461000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 689636000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 689636000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 158611000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 158611000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 123395000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 123395000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 5971324000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 3197888000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Normalized Income: 3623004800.96
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 2126726000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 3466804000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Operating Income: 4900236000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Operating Income: 2822417000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Operating Revenue: 19321190000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 7762503000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 12829889.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 12829889.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 721863000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 721863000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 86773000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 86773000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 18615724000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 18615724000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 62658000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 62658000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 138920000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 416025000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 416025000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 301662000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 124582000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 658825000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 494350000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Other Payable: 312123000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 312123000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Other Properties: 8922876000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 8922876000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 117419000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 117419000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 2500000000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 2500000000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Other Special Charges: 52738000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Payables: 3187448000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Payables: 3187448000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 412263000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 412263000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 647825000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 647825000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Pretax Income: 4889771000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 2874948000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -20467000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -3013719000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -3971321000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 2221274000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 2221274000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 9471166000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3210130000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 917395000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 250889000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 15911000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 15911000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -447178000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 282945000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 282945000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 13432325000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 13432325000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 2652374000.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Sale Of Investment Properties: 0.00
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 9263000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 308996000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 830237000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Share Issued: 12829889.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 12829889.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Special Income Charges: -52738000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 18744729000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 18744729000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 15887461000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 15887461000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 5829800.96
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Tax Provision: 1249787000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 748222000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.26
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
NEULANDLAB.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -1035277000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Total Assets: 29301377000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 29301377000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 20354202000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 20354202000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Total Debt: 3012722000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 3012722000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 18744729000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 18744729000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Total Expenses: 14420954000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 4940086000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 10556648000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 10556648000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 14470089000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 14470089000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3454668000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3454668000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 52507000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 181556000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 181556000.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 22809000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
NEULANDLAB.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 22809000.00
NEULANDLAB.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Work In Process: 2495808000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 2495808000.00
NEULANDLAB.NS balance_sheet (annual, 2026-03-31) — Working Capital: 7729308000.00
NEULANDLAB.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 7729308000.00
NEUP income_statement (annual, 2021-06-30) — +Operating Expense: 8957654.63
NEUP income_statement (annual, 2021-06-30) — +Total Revenue: 0.00
NEUP balance_sheet (annual, 2021-06-30) — Accounts Payable: 772933.82
NEUP balance_sheet (annual, 2021-06-30) — Accounts Receivable: 144771.44
NEUP balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -1209585.56
NEUP income_statement (annual, 2021-06-30) — Amortization: 892512.00
NEUP income_statement (annual, 2021-06-30) — Amortization Of Intangibles Income Statement: 892512.00
NEUP cash_flow (annual, 2021-06-30) — Beginning Cash Position: 3439432.44
NEUP cash_flow (annual, 2021-06-30) — Capital Expenditure: -1102.96
NEUP balance_sheet (annual, 2021-06-30) — Capital Lease Obligations: 652041.38
NEUP balance_sheet (annual, 2021-06-30) — Capital Stock: 142896966.85
NEUP balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 21412701.36
NEUP balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 21412701.36
NEUP balance_sheet (annual, 2021-06-30) — Cash Financial: 21412701.36
NEUP cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: 23707478.81
NEUP cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Investing Activities: -60261.77
NEUP cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Operating Activities: -5664125.14
NEUP cash_flow (annual, 2021-06-30) — Cash Flowsfromusedin Operating Activities Direct: -5664125.14
NEUP cash_flow (annual, 2021-06-30) — Change In Inventory: 0.00
NEUP cash_flow (annual, 2021-06-30) — Change In Other Current Assets: -64350.54
NEUP cash_flow (annual, 2021-06-30) — Change In Other Current Liabilities: 0.00
NEUP cash_flow (annual, 2021-06-30) — Change In Other Working Capital: -182837.95
NEUP cash_flow (annual, 2021-06-30) — Change In Payable: -47563.41